Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family
Giulia Cini(National Cancer Institute), Alessandra Viel(Centro di Riferimento Oncologico), Elisa Giacomini(National Cancer Institute), Paola Sala(Istituti di Ricovero e Cura a Carattere Scientifico), Ileana Carnevali(University of Insubria), Michele Quaia(National Cancer Institute), Maria Grazia Tibiletti(University of Insubria), Anna Maria Chiaravalli(Ospedale di Circolo e Fondazione Macchi), Roberta Maestro(Centro di Riferimento Oncologico)
Cited by 42
Related Papers
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
twist is a potential oncogene that inhibits apoptosis
|Genes & Development|1999|508